US Drug Recall Register
Class II · Moderate risk Terminated Initiated Dec 12, 2012 (14 years ago)

Temodar (temozolomide) Capsule, 20 mg per capsule, 5 capsules per package, For Oral…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Impurities/Degradation Specifications: The recall is being initiated due to an out-of-specification result in the degradation product testing detected during stability monitoring.

What was recalled

Temodar (temozolomide) Capsule, 20 mg per capsule, 5 capsules per package, For Oral Administration, Rx Only, Cytotoxic, NDC: 0085-1519-02, Schering Corporation, Kenilworth, New Jersey, 07033

Recalling firm
Schering-Plough Products, LLC
Origin
PR, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-139-2013

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Temozolomide recalls

See all